Detke Michael J. 4
4 · Cortexyme, Inc. · Filed May 29, 2020
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
Detke Michael J.
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-05-27−5,515→ 104,091 totalExercise: $6.91Exp: 2029-02-05→ Common Stock (5,515 underlying) - Exercise/Conversion
Common Stock
2020-05-27$6.91/sh+5,515$38,109→ 28,261 total
Footnotes (1)
- [F1]The option vested as to 25% of the shares on December 16, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on January 16, 2020 and ending on December 16, 2022.